News
On this week's podcast, STAT's Helen Branswell talks about BARDA cancelling its contract with Moderna and RFK Jr. taking an ...
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results